These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
313 related articles for article (PubMed ID: 11306494)
21. Frequent epigenetic inactivation of the RASSF1A gene in hepatocellular carcinoma. Schagdarsurengin U; Wilkens L; Steinemann D; Flemming P; Kreipe HH; Pfeifer GP; Schlegelberger B; Dammann R Oncogene; 2003 Mar; 22(12):1866-71. PubMed ID: 12660822 [TBL] [Abstract][Full Text] [Related]
22. Frequent epigenetic inactivation of RASSF1A and BLU genes located within the critical 3p21.3 region in gliomas. Hesson L; Bièche I; Krex D; Criniere E; Hoang-Xuan K; Maher ER; Latif F Oncogene; 2004 Mar; 23(13):2408-19. PubMed ID: 14743209 [TBL] [Abstract][Full Text] [Related]
23. Detection of RASSF1A aberrant promoter hypermethylation in sputum from chronic smokers and ductal carcinoma in situ from breast cancer patients. Honorio S; Agathanggelou A; Schuermann M; Pankow W; Viacava P; Maher ER; Latif F Oncogene; 2003 Jan; 22(1):147-50. PubMed ID: 12527916 [TBL] [Abstract][Full Text] [Related]
24. Biallelic epigenetic inactivation of the RASSF1A tumor suppressor gene in medulloblastoma development. Lusher ME; Lindsey JC; Latif F; Pearson AD; Ellison DW; Clifford SC Cancer Res; 2002 Oct; 62(20):5906-11. PubMed ID: 12384556 [TBL] [Abstract][Full Text] [Related]
25. RASSF3 and NORE1: identification and cloning of two human homologues of the putative tumor suppressor gene RASSF1. Tommasi S; Dammann R; Jin SG; Zhang XF; Avruch J; Pfeifer GP Oncogene; 2002 Apr; 21(17):2713-20. PubMed ID: 11965544 [TBL] [Abstract][Full Text] [Related]
26. Methylation of the RASSF1A gene in human cancers. Pfeifer GP; Yoon JH; Liu L; Tommasi S; Wilczynski SP; Dammann R Biol Chem; 2002 Jun; 383(6):907-14. PubMed ID: 12222680 [TBL] [Abstract][Full Text] [Related]
27. The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines. Sato M; Horio Y; Sekido Y; Minna JD; Shimokata K; Hasegawa Y Oncogene; 2002 Jul; 21(31):4822-9. PubMed ID: 12101420 [TBL] [Abstract][Full Text] [Related]
28. Frequent promoter hypermethylation of RASSF1A and CASP8 in neuroblastoma. Lázcoz P; Muñoz J; Nistal M; Pestaña A; Encío I; Castresana JS BMC Cancer; 2006 Oct; 6():254. PubMed ID: 17064406 [TBL] [Abstract][Full Text] [Related]
29. Promoter hypermethylation of RASSF1A in esophageal squamous cell carcinoma. Kuroki T; Trapasso F; Yendamuri S; Matsuyama A; Alder H; Mori M; Croce CM Clin Cancer Res; 2003 Apr; 9(4):1441-5. PubMed ID: 12684417 [TBL] [Abstract][Full Text] [Related]
30. Hypermethylation of the RASSF1A gene in gliomas. Gao Y; Guan M; Su B; Liu W; Xu M; Lu Y Clin Chim Acta; 2004 Nov; 349(1-2):173-9. PubMed ID: 15469871 [TBL] [Abstract][Full Text] [Related]
31. Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients. Dulaimi E; Hillinck J; Ibanez de Caceres I; Al-Saleem T; Cairns P Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6189-93. PubMed ID: 15448006 [TBL] [Abstract][Full Text] [Related]
32. Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter 1A in breast and lung carcinomas. Virmani AK; Rathi A; Sathyanarayana UG; Padar A; Huang CX; Cunnigham HT; Farinas AJ; Milchgrub S; Euhus DM; Gilcrease M; Herman J; Minna JD; Gazdar AF Clin Cancer Res; 2001 Jul; 7(7):1998-2004. PubMed ID: 11448917 [TBL] [Abstract][Full Text] [Related]
33. Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines. Harada K; Toyooka S; Maitra A; Maruyama R; Toyooka KO; Timmons CF; Tomlinson GE; Mastrangelo D; Hay RJ; Minna JD; Gazdar AF Oncogene; 2002 Jun; 21(27):4345-9. PubMed ID: 12082624 [TBL] [Abstract][Full Text] [Related]
34. CpG island promoter hypermethylation of a novel Ras-effector gene RASSF2A is an early event in colon carcinogenesis and correlates inversely with K-ras mutations. Hesson LB; Wilson R; Morton D; Adams C; Walker M; Maher ER; Latif F Oncogene; 2005 Jun; 24(24):3987-94. PubMed ID: 15806169 [TBL] [Abstract][Full Text] [Related]
35. Epigenetic inactivation of RASSF1a in uveal melanoma. Maat W; van der Velden PA; Out-Luiting C; Plug M; Dirks-Mulder A; Jager MJ; Gruis NA Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):486-90. PubMed ID: 17251440 [TBL] [Abstract][Full Text] [Related]
36. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours. Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564 [TBL] [Abstract][Full Text] [Related]
37. K-ras mutations and RASSF1A promoter methylation in colorectal cancer. van Engeland M; Roemen GM; Brink M; Pachen MM; Weijenberg MP; de Bruïne AP; Arends JW; van den Brandt PA; de Goeij AF; Herman JG Oncogene; 2002 May; 21(23):3792-5. PubMed ID: 12032847 [TBL] [Abstract][Full Text] [Related]
39. SLIT2, a human homologue of the Drosophila Slit2 gene, has tumor suppressor activity and is frequently inactivated in lung and breast cancers. Dallol A; Da Silva NF; Viacava P; Minna JD; Bieche I; Maher ER; Latif F Cancer Res; 2002 Oct; 62(20):5874-80. PubMed ID: 12384551 [TBL] [Abstract][Full Text] [Related]
40. Expression and promoter methylation of the RASSF1A gene in sporadic breast cancers in Chinese women. Li Y; Wei Q; Cao F; Cao X Oncol Rep; 2008 May; 19(5):1149-53. PubMed ID: 18425370 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]